Vesicoureteral Reflux (VUR) – Endoscopic Correction
The endoscopic correction of vesicoureteral reflux (VUR) in children is a currently well-accepted therapy in many pediatric urology centers.
Endoscopic management of VUR in children since the introduction of subureteric injection of bulking substance about 30 years ago, has become a first line procedure for the interventional treatment of all grades of reflux in children in many pediatric institutions.
Currently, the bulking agent that is endoscopically injected around the ureteral opening, is a biodegradable substance. The overall success results reported in the literature after the endoscopic correction of VUR in children with the most widely used bulking agent, DX/Ha - hyaluronic acid (HA) and dextranomer (Dx) -– range between 68% and 92%, taking into consideration the reflux grade. The low VUR grades have the best results. The high VUR grades may need a second injection for a total resolution of VUR.
It is a day clinic procedure, and it is performed under general anesthesia.
The surgical correction (open surgery) is still indicated in distinguished anatomic variations of the low urinary tract and in the cases with endoscopic therapy failure.